a preliminary analysis of oral contraceptive use in young nulliparous women , who had no family history of either breast cancer or benign breast disease , showed a statistically significant dose-response , with long-term users ( 49 months or more ) having an apparent 4-fold elevation in risk of early breast cancer .
C0006141
breast
C0016034
benign